ANVS · Annovis Bio, Inc. · Executive Compensation
$1.21
+0.04 (+3.42%)
At close · Oct 9
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has concluded that substantial doubt exists about the Company's ability to continue as a going concern. Management's plans to mitigate this risk include raising additional capital through equity financings, debt, or other potential alternatives. Management's plans may also include the deferral of certain operating expenses unless and until additional capital is received. However, there can be no assurance that the Company will be successful in raising additional capital or that such capital, if available, will be on terms that are acceptable to the Company, or that the Company will be successful in deferring certain operating expenses. As such, Management has concluded that such plans do not alleviate the aforementioned substantial doubt.”View the 10-Q filed Aug 14, 2026
Market Cap
$51.55M
Shares
42.61M
Volume · Oct 9
521.9K
Avg daily vol (3M)
880.06K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Maria Maccecchini | President and Chief Executive Officer and Acting CFO | $808,000 |
| Mark Guerin | — | $234,500 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Maria Maccecchini | President and Chief Executive Officer and Acting CFO | $2,327,667 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Maria Maccecchini | President and Chief Executive Officer | $2,788,838 |
| Henry Hagopian III | Chief Financial Officer (post August 29, 2022) | $490,873 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Maria Maccecchini | President and Chief Executive Officer | $2,654,429 |
| Henry Hagopian III | Chief Financial Officer | $1,417,257 |
| Jeffrey McGroarty | Former Chief Financial Officer | $964,259 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Maria Maccecchini | President and Chief Executive Officer | $8,586,137 |
| Jeffrey McGroarty | Former Chief Financial Officer | $4,978,184 |
| Henry Hagopian III | Chief Financial Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Maria Maccecchini | President and Chief Executive Officer | $1,014,232 |
| Jeffrey McGroarty | Chief Financial Officer | $894,232 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Maria Maccecchini | President and Chief Executive Officer | $120,000 |
| Jeffrey McGroarty | Chief Financial Officer | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Maria Maccecchini | President and Chief Executive Officer | $155,165 |
| Jeffrey McGroarty | Chief Financial Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Mark Guerin | Chief Financial Officer | Terminated | 2026-03-25 |
| Mark Guerin | Chief Financial Officer | Appointed | 2025-09-29 |
| Andrew Walsh | Vice President of Finance, the Company's Principal Financial Officer | Resigned | 2025-08-15 |
| Andrew Walsh | Principal Financial Officer | Appointed | 2025-05-13 |
| William Fricker | Interim Chief Financial Officer | Resigned | 2025-03-27 |
| William Fricker | Chief Financial Officer | Appointed | 2024-12-09 |
| Henry Hagopian | Chief Financial Officer and principal financial officer | Resigned | 2024-05-01 |
| Jeffrey B. McGroarty | Chief Financial Officer | Terminated | 2022-09-12 |
| Henry Hagopian III | Chief Financial Officer | Appointed | 2022-08-30 |